Screener
Innospec IOSP Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by Innospec in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The source filing: Innospec’s 10-Q, filed May 8, 2026.
- Filed
- May 8, 2026, 9:34 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-213510
| Liabilities and Equity / Current liabilities: | ||
|---|---|---|
| Pension liabilities and post-employment benefits | 12.8 | 13.2 |
| Acquisition-related contingent consideration | 1.3 | 1.3 |
| Other non-current liabilities | 4.5 | 8.8 |
| Total liabilities | 467.6 | 499.5 |
| Equity: | ||
| Common stock, $0.01 par value, authorized 40,000,000 shares, issued 29,554,500 shares | 0.3 | 0.3 |
| Additional paid-in capital | 377.3 | 376.5 |
| Treasury stock (4,836,364 and 4,776,918 shares at cost, respectively) | (121.4) | (115.2) |
Item 1 Condensed Consolidated Financial Statements
FAQ
- What is Innospec's total liabilities?
- Innospec (IOSP) reported total liabilities of $467.6M in Q1 2026.
- How has Innospec's total liabilities changed year-over-year?
- Innospec's total liabilities decreased by 8.1% year-over-year, from $508.9M to $467.6M.
- What is the long-term trend for Innospec's total liabilities?
- Over 4 years (2021 to 2025), Innospec's total liabilities has grown at a -1.8% compound annual growth rate (CAGR), from $537.9M to $499.5M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.
Ask your AI about Innospec's total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude